"The initial payment will help cover substantially
Post# of 72440
(Total Views: 374)
Posted On: 07/29/2019 9:50:05 AM
"The initial payment will help cover substantially the costs of our upcoming clinical study of oral-dosed Brilacidin currently being developed for treating Ulcerative Colitis (UC). "
A normal Phase 2 costs are roughly $7m-$20m so the up front payment is not $1m like some suggest.
A normal Phase 2 costs are roughly $7m-$20m so the up front payment is not $1m like some suggest.
(0)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Leo Took The Money and Ran
Scroll down for more posts ▼